S
I NeE the publication of the monograph Vitamin C and the Common Cold, by Linus Pauling (1970) , there has been much discussion in the public press and elsewhere both in America and in this country on the prophylactic and therapeutic value of ascorbic acid in infections by the common cold virus.
During the winter of 1971, we were able to observe the changes occurring in the leucocyte ascorbic acid levels (L.A.A.) in 7 individual members of the staff of one medical unit in a general hospital, during an outbreak of the common cold. Ascorbic acid saturation tests were also carried out to determine whether there was an optimum dose of ascorbic acid which would saturate both the white blood cells and the serum. The effect of 'optimum' doses of ascorbic acid during further episodes of the common cold was studied in 3 individuals." In view of the difficulty in carrying out detailed studies on individuals who are harbouring the common cold virus and who are taking supplements of ascorbic acid, we felt that these observations also were worth reporting.
MATERIAL AND METHODS Subjects Seven members (2 males and 5 females) of the medical and nursing staff were studied while suffering from the common cold. By chance, 4 individuals had measurements of their L.A.A. performed during the week prior to the onset of symptoms. Six individuals had measurements performed on the first day of symptoms; 5 on the second day of symptoms; 7 on the third day of symptoms; 5 on the fourth day of symptoms; 3 on the fifth day of symptoms and 7 on the tenth day of symptoms. Symptoms had usually subsided by the fifth day.
Ascorbic acid saturation studies Following the 'colds', the 7 subjects agreed to take ascorbic acid daily, increasing the amount at weekly intervals. During the first week 0.2 g. of ascorbic acid was taken daily, during the second week 1.0 g. of ascorbic acid was taken daily, during the third week 3.0 g. of ascorbic acid daily and during the fourth week 6.0 g. of ascorbic acid daily. Four individuals volunteered to take 10.0 g. of ascorbic acid daily, during the fifth week. The L.A.A. and the serum ascorbic acid (S.A.A.) were measured on 2 occasions each week in each individual and the mean of the 2 readings was used as the saturation level on that particular dose of ascorbic acid.
There were, therefore, 14 readings on the 7 subjects each week and 8 readings on the 4 subjects on the fifth week of observation. Most subjects experienced abdominal colic and some looseness of the bowels on first taking 3.0 g. of ascorbic acid per day. However, this did not persist and there were no other side effects. The ascorbic acid was administered in divided doses in the form of effervescent ascorbic acid (Roche). Leucocyte ascorbic acid (L.A.A.) was measured by the method of Bessey et al. (1947) as modified by Denson and Bowers (1961) (S.D. ± 3.5). On day 3 of symptoms the mean L.A.A. level for 7 subjects was 14.6,ug. Ascorbic acid saturation studies (Table II, (Hume et al., 1972) . It would appear, therefore, that both major and minor 'stresses' can have a profound effect on L.A.A. rendering interpretation ofan isolated L.A.A. difficult unless account is taken of the circumstances under which the test is carried out.
Having observed these changes in L.A.A. following an episode of the common cold, and in view of the controversy regarding the effect of ascorbic acid both as a prophylactic' and a therapeutic agent, we wondered whether supplements of ascorbic acid could alter this pattern. The first observation that supplements of 0.2 g. ascorbic acid per day did not alter the pattern of L.A.A. during the common cold (Fig. 4) prompted saturation studies in normal individuals to determine the amount of ascorbic acid per day required to saturate the leucocytes and the serum. Within the limitations of the studies carried out, it was not possible to show a significant rise in L.A.A. on increasing the ingested amount of ascorbic acid from 1.0 g. per day to 10.0 g. per day either by comparison of the means or analysis of variance (Fig. 2) . Interestingly, the fall in L.A.A. (which did not reach statistical levels), on starting 3.0 g. of ascorbic acid per day was, in nearly all subjects, associated with abdominal colic and looseness of the bowels suggesting the fall was due to malabsorption of the ascorbic acid. However, bowel symptoms did not persist and there were no other side effects. With regard to the serum, it was not possible to show an increase in ascorbic acid concentration on increasing the ingestion of ascorbic acid from 6.0 g. per day to 10.0 g. per day either by comparison of the means or analysis of variance (Fig. 2) . While aware of the statistical hazards implicit in analysis of such small numbers of observations and the limited range of ascorbic acid doses used, nevertheless, it was decided on the evidence to use 1.0 g. per day as a prophylactic and 6.0 g. per day as a therapeutic dose. The 4 'colds' experienced by 3 of the individuals who volunteered to take 1.0 g. per day throughout the winter months and 6.0 g. for 3 days at the first appearance of cold symptoms are shown in Figure 3 . It can be seen that the peak fall in L.A.A. has occurred on day 3 of symptoms instead of day one as in the unsupplemented group and that the lowest recorded L.A.A. in each case is still within the normal range. Pre-cold levels of L.A.A. are reached again in the fourth or fifth day. The cold symptoms persisted for 2 to 3 days. While the number of subjects involved in these observations is small, nevertheless, the pattern of change of L.A.A. during the common cold is so consistent in each individual and the effect of ascorbic acid feeding so clear cut, we feel the small numbers do not detract from the results. With regard to the saturation studies, it has been claimed that L.A.A. saturation may be obtained by smaller amounts of ascorbic acid administered over a longer period of time (Goldsmith, 1961; Brocklehurst et al., 1968; Andrews, et al 1969; Wilson & Loh, 1969; Booth & Todd, 1970; Loh & Wilson, 1971a; Loh & Wilson, 1971b) . The value of more prolonged courses of smaller amounts of ascorbic acid and more acute courses of larger amounts of ascorbic acid as a prophylactic or therapeutic agent in the common cold have produced only discrepant reports. (Cowan et al., 1942; Bartley et al., 1953; Ritzel, 1961; Glazebrook & Thomson, 1962; Walker et al., 1967; Regnier, 1969; Wilson & Loh, 1969; Wilson, 1971) . We feel a further trial would be justified along the lines suggested here, namely, 1.0 g. ascorbic acid per day as a prophylactic and 6.0 g. or 10.0 g. per day as a therapeutic measure after challenge by the common cold virus. Those suggestions are not incompatible with the recommendations of Linus Pauling (1970) who suggests I to 2 g. per day for good health and 4 to 10 g. per day to combat the common cold.
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